Diagnostic ability of linked color imaging in ultraslim endoscopy to identify neoplastic lesions in the upper gastrointestinal tract

Abstract

Background and study aims Linked color imaging (LCI) is a new image-enhancing technique that facilitates the differentiation of slight differences in mucosal color tone. We performed an exploratory analysis to evaluate the diagnostic capability of LCI in ultraslim endoscopy, using data from patients examined in the LCI-Further Improving Neoplasm Detection in upper gastrointestinal (LCI-FIND) trial, a large-scale, multicenter, randomized controlled trial that demonstrated the capability of LCI for detecting neoplastic lesions in the upper gastrointestinal tract.

Patients and methods Data from the LCI-FIND prospective trial were used. In the LCI-FIND trial, 1502 patients with a history of gastrointestinal cancer were randomly assigned to two groups based on examination methods: white light imaging (WLI) followed by LCI (WLI group) and LCI followed by WLI (LCI group). The present exploratory analysis investigated the outcomes of patients who underwent ultraslim and standard endoscopies.

Results Ultraslim endoscopes were used in 223 patients and standard endoscopes in 1279 patients. The primary endpoint of the LCI-FIND trial was the percentage of patients diagnosed with a neoplastic lesion using WLI or LCI. The corresponding percentage tended to be higher with LCI than with WLI among patients who underwent ultraslim endoscopy and among those who underwent standard endoscopy; the crude risk ratio was 2.21 [95 % confidence interval (CI): 1.06–4.67], and the adjusted odds ratio was 2.46 (95 % CI: 1.07–5.63).

Conclusions Our exploratory analysis of data from the LCI-FIND trial showed that LCI is useful in identifying neoplastic lesions, when used in ultraslim endoscopy.

Publikationsverlauf

Eingereicht: 03. Mai 2021

Angenommen nach Revision: 12. Oktober 2021

Artikel online veröffentlicht:
14. Januar 2022

• References

• 1 Hosokawa O, Tsuda S, Kidani E. et al. Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy. Endoscopy 1998; 30: 669-674
• 2 Hosokawa O, Hattori M, Douden K. et al. Difference in accuracy between gastroscopy and colonoscopy for detection of cancer. Hepatogastroenterology 2007; 54: 442-444
• 3 Suvakovic Z, Bramble MG, Jones R. et al. Improving the detection rate of early gastric cancer requires more than open access gastroscopy: a five-year study. Gut 1997; 41: 308-313
• 4 Fukuda H, Miura Y, Hayashi Y. et al. Linked color imaging technology facilitates early detection of flat gastric cancers. Clin J Gastroenterol 2015; 8: 385-389
• 5 Sun X, Dong T, Bi Y. et al. Linked color imaging application for improving the endoscopic diagnosis accuracy: a pilot study. Sci Rep 2016; 6: 33473
• 6 Dohi O, Yagi N, Onozawa Y. et al. Linked color imaging improves endoscopic diagnosis of active Helicobacter pylori infection. Endosc Int Open 2016; 4: E800-E805
• 7 Mizukami K, Ogawa R, Okamoto K. et al. Objective endoscopic analysis with linked color imaging regarding gastric mucosal atrophy: a pilot study. Gastroent Res Pract 2017; 2017: 5054237
• 8 Ono S, Abiko S, Kato M. Linked color imaging enhances gastric cancer in gastric intestinal metaplasia. Dig Endosc 2017; 29: 230-231
• 9 Yoshifuku Y, Sanomura Y, Oka S. et al. Evaluation of the visibility of early gastric cancer using linked color imaging and blue laser imaging. BMC Gastroenterol 2017; 17: 150
• 10 Kanzaki H, Takenaka R, Kawahara Y. et al. Linked color imaging (LCI-, a novel image-enhanced endoscopy technology, emphasizes the color of early gastric cancer. Endosc Int Open 2017; 5: E1005-E1013
• 11 Sun X, Bi Y, Dong T. et al. Linked color imaging benefits the endoscopic diagnosis of distal gastric diseases. Sci Rep 2017; 7: 5638
• 12 Kitagawa Y, Hara T, Ikebe D. et al. Magnified endoscopic observation of small depressed gastric lesions using linked color imaging with indigo carmine dye. Endoscopy 2018; 50: 142-147
• 13 Ono S, Kato M, Tsuda M. et al. Lavender color in linked color imaging enables noninvasive detection of gastric intestinal metaplasia. Digestion 2018; 98: 222-230
• 14 Fukuda H, Miura Y, Osawa H. et al. Linked color imaging can enhance recognition of early gastric cancer by high color contrast to surrounding gastric intestinal metaplasia. J Gastroenterol 2019; 54: 396-406
• 15 Ono S, Kawada K, Dohi O. et al. Linked color imaging focused on neoplasm detection in the upper gastrointestinal tract: a randomized trial. Ann Intern Med 2021; 174: 18-24
• 16 Nakata H, Enomoto S, Maekita T. et al. Transnasal and standard transoral endoscopies in the screening of gastric mucosal neoplasias. World J Gastrointest Endosc 2011; 3: 162-170
• 17 Osawa H, Miura Y, Takezawa T. et al. Linked color imaging and blue laser imaging for gastrointestinal screening. Clin Endosc 2018; 51: 513-526
• 18 Shinozaki S, Osawa H, Hayashi Y. et al. Linked color imaging for the detection of early gastrointestinal neoplasms. Ther Adv Gastroenterol 2019; 12: 1-10